Dhulia, I., H. Patel, N. Chauhan, and N. Pardeshi. “FDA’s Drug Regulatory Pathways, Its Development Strategies and Regulatory Considerations”. International Journal of Drug Regulatory Affairs, Vol. 9, no. 2, June 2021, pp. 6-15, doi:10.22270/ijdra.v9i2.460.